Dublin, May 13, 2025 (GLOBE NEWSWIRE) -- The "Asia-Pacific Precision Medicine Market: Focus on Ecosystem and Country - Analysis and Forecast, 2024-2034" report has been added to ResearchAndMarkets.com's offering.
The Asia-Pacific precision medicine market is projected to reach $158.92 billion by 2034 from $40.44 billion in 2024, at a CAGR of 14.67% during the forecast period of 2024-2034.
The precision medicine industry in the APAC area is being driven by developments in genetic research, diagnostics, and targeted medicines. The increasing incidence of chronic illnesses, the incorporation of digital health solutions, and a heightened emphasis on individualised patient care are the main drivers of this expansion. The development of customised medicines is being accelerated by government initiatives and cooperative research alliances, which is improving patient results.
Furthermore, with the growing use of biomarkers, next-generation sequencing, and AI-driven diagnostics, the treatment of oncology, cardiology, and uncommon diseases is changing dramatically. Ongoing investments in healthcare infrastructure and increased public knowledge of the advantages of personalised therapy are two more factors contributing to the quick adoption of precision medicine in many healthcare settings. These developments are establishing the Asia-Pacific area as a vibrant centre for cutting-edge medical research and technology, resulting in more individualised, successful treatment plans and a move towards precise, patient-centered care.
Market Trends, Drivers and Challenges of the APAC Precision Medicine Market
Advances in genetic research, AI-powered diagnostics, and digital health technologies that are transforming conventional healthcare are propelling the APAC precision medicine market's rapid expansion. The need for individualised care and customised therapeutic techniques has increased due to the rising incidence of uncommon, cancerous, and chronic illnesses. Significant market drivers include government programs, large investments, and cooperative research between biotech, pharmaceutical, and academic organisations. Market expansion is further bolstered by favourable regulatory frameworks and continuous advancements in healthcare infrastructure.
But there are still issues like the expensive price of sophisticated diagnostic instruments, the necessity for strong cybersecurity and safe data integration, and the various legal requirements in different nations. Further impeding wider adoption are disparities in healthcare availability and awareness within the region. Notwithstanding these challenges, the APAC precision medicine industry is emerging as a key player in revolutionising patient-centered care and producing better clinical results thanks to sustained technical advancement and robust government backing.
Key Market Players and Competition Synopsis
Profiled companies have been selected based on inputs gathered from primary experts, as well as analyzing company coverage, product portfolio, and market penetration. Some prominent names established in this market are:
- Astellas Pharma Inc.
- Konica Minolta, Inc.
- Sysmex Corporation
How can this report add value to an organization?
Product/Innovation Strategy: The report offers in-depth insights into the latest technological advancements in precision medicine, enabling organizations to drive innovation and develop cutting-edge products tailored to market needs.
Growth/Marketing Strategy: By providing comprehensive market analysis and identifying key growth opportunities, the report equips organizations with the knowledge to craft targeted marketing strategies and expand their market presence effectively.
Competitive Strategy: The report includes a thorough competitive landscape analysis, helping organizations understand their competitors' strengths and weaknesses and allowing them to strategize effectively to gain a competitive edge in the market.
Key Attributes
| Report Attribute | Details |
| No. of Pages | 75 |
| Forecast Period | 2024-2034 |
| Estimated Market Value (USD) in 2024 | $40.44 Billion |
| Forecasted Market Value (USD) by 2034 | $158.92 Billion |
| Compound Annual Growth Rate | 14.6% |
| Regions Covered | Asia Pacific |
Key Topics Covered
1 Market Overview
1.1 Market Definition
1.2 Precision Medicine: A Frontier in the Genesis of Patient-Centric Medicine
1.3 Precision Medicine: Remodeling the One-Size-Fits-All Theory to Individually Tailored Therapy
1.4 Initiatives and Programs
1.5 Precision Medicine: Enabling Technologies and Applications
1.5.1 Innovators
1.5.1.1 3D DNA Printing
1.5.1.2 RNA-Seq
1.5.1.3 4D Molecular Imaging
1.5.2 Early Adopters
1.5.2.1 CRISPR
1.5.2.2 Blockchain
1.5.2.3 Imaging Informatics
1.5.3 Early Majority
1.5.3.1 Artificial Intelligence (AI)
1.5.3.2 Circulating Free DNA (cfDNA)
1.5.3.3 Big Data
1.5.3.4 Next-Generation Sequencing (NGS)
1.5.3.5 Health Informatics
1.5.3.6 Bioinformatics
1.5.4 Late Majority
1.5.4.1 Polymerase Chain Reactions (PCR)
1.5.4.2 Microarray
2 Market: Industry Outlook
2.1 Precision Medicine Market: Ecosystem Analysis
2.2 Market Trends
2.2.1 Integrating Advanced Imaging for Enhanced Diagnostics and Treatment
2.2.2 Emergence of Biobanks as a Cornerstone of Precision Medicine
2.3 Industry Insights
2.3.1 Patent Analysis
2.3.2 Pipeline Analysis
2.3.3 Legal Requirements and Framework by the MHLW
2.4 Ecosystem Summary
3 Region
3.1 Overview
3.2 Asia-Pacific
3.2.1 Regional Overview
3.2.2 Driving Factors for Market Growth
3.2.3 Factors Challenging the Market
3.2.4 Japan
3.2.5 China
3.2.6 India
3.2.7 Australia
3.2.8 South Korea
3.2.9 Rest-of-APAC
4 Competitive Landscape
4.1 Competitive Landscape
4.1.1 Synergistic Activities
4.2 Company Profiles
4.2.1 Astellas Pharma Inc.
4.2.1.1 Overview
4.2.1.2 Top Products
4.2.1.3 Top Competitors
4.2.1.4 Analyst View
4.2.2 Sysmex Corporation
4.2.2.1 Overview
4.2.2.2 Top Products
4.2.2.3 Top Competitors
4.2.2.4 Analyst View
4.2.3 Konica Minolta, Inc.
4.2.3.1 Overview
4.2.3.2 Top Products/Product Portfolio
4.2.3.3 Top Competitors
4.2.3.4 Analyst View
5 Research Methodology
5.1 Precision Medicine Market: Research Methodology
5.1.1 Data Sources
5.1.1.1 Primary Data Sources
5.1.1.2 Secondary Data Sources
5.1.2 Data Triangulation
5.2 Market Estimation and Forecast
For more information about this report visit https://www.researchandmarkets.com/r/cfgk66
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
